The differences between the branded and generic medicines using solid dosage forms: In-vitro dissolution testing
Open Access
- 1 January 2012
- journal article
- Published by Elsevier in Results in Pharma Sciences
- Vol. 2, 1-8
Abstract
No abstract availableKeywords
Funding Information
- William Harvey Research Institute
- Government of the United Arab Emirates
This publication has 22 references indexed in Scilit:
- Developing the Nation's Biosimilars ProgramNew England Journal of Medicine, 2011
- A survey to determine the views of renal transplant patients on generic substitution in the UKTransplant International, 2011
- Dissolution test optimization for meloxicam in the tablet pharmaceutical formBrazilian Journal of Pharmaceutical Sciences, 2009
- The Ongoing Regulation of Generic DrugsNew England Journal of Medicine, 2007
- A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification SystemInternational Journal of Pharmaceutics, 2006
- Diclofenac sodium multisource prolonged release tablets—a comparative study on the dissolution profilesJournal of Pharmaceutical and Biomedical Analysis, 2005
- Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodiumIl Farmaco, 2005
- Validation of Tablet Dissolution Method by High-Performance Liquid ChromatographyDrug Development and Industrial Pharmacy, 2000
- Dissolution testing for sustained or controlled release oral dosage forms and correlation with in vivo data: Challenges and opportunitiesInternational Journal of Pharmaceutics, 1996
- Correlation between dissolution rate and bioavailability of different commercial mefenamic acid capsulesInternational Journal of Pharmaceutics, 1984